Progenics Pharmaceuticals — Tarrytown, New York

Progenics Pharmaceuticals is a clinical research site located in Tarrytown, New York, United States 10591.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Progenics Pharmaceuticals has participated in 26 clinical trials.

Therapeutic areas: Healthy Males, Prostate Cancer, HIV -1 Infection.

Sponsors: Bausch Health Americas, Inc., Progenics Pharmaceuticals, Inc., CytoDyn, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tarrytown

Browse all research sites in New York · View every site in Tarrytown

• Northwell Health- Phelps Hospital
• Columbia University
• Regeneron Research Site
• Regeneron Research Facility
• PaxMedica
• Pediatric Urology Associates PC
• Site US1008 Pediatric Urology Associates, P.C.
• Pediatric Urology Associates
• Regeneron
• IMA Evaluations, LLC dba IMA Clinical Research
• Site US1008

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Progenics Pharmaceuticals?

Progenics Pharmaceuticals has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Progenics Pharmaceuticals conducted?

Progenics Pharmaceuticals has 26 clinical trials on record. Their work covers Healthy Males, Prostate Cancer, HIV -1 Infection.

Is Progenics Pharmaceuticals accredited by Crixeo Clinical Trials?

Progenics Pharmaceuticals has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Progenics Pharmaceuticals?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.